TY - BOOK AU - Strosberg, J. R. AU - Wolin, E. M. AU - Chasen, B. PY - 2016 DA - 2016// TI - NETTER-1 phase III: Progression-free survival, radiographic response, and preliminary overall survival results in patients with midgut neuroendocrine tumors treated with 177-Lu-dotatate ID - Strosberg2016 ER - TY - JOUR AU - Ljungberg, M. AU - Celler, A. AU - Konijnenberg, M. W. AU - Eckerman, K. F. AU - Dewaraja, Y. K. AU - Sjögreen-Gleisner, K. PY - 2016 DA - 2016// TI - MIRD pamphlet no. 26: joint EANM/MIRD guidelines for quantitative 177Lu SPECT applied for dosimetry of radiopharmaceutical therapy JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.115.159012 DO - 10.2967/jnumed.115.159012 ID - Ljungberg2016 ER - TY - JOUR AU - Zaknun, J. J. AU - Bodei, L. AU - Mueller-Brand, J. AU - Pavel, M. E. AU - Baum, R. P. AU - Hörsch, D. AU - O’Dorisio, M. S. AU - O’Dorisiol, T. M. AU - Howe, J. R. AU - Cremonesi, M. AU - Kwekkeboom, D. J. PY - 2013 DA - 2013// TI - The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours JO - Eur J Nucl Med Mol Imaging VL - 40 UR - https://doi.org/10.1007/s00259-012-2330-6 DO - 10.1007/s00259-012-2330-6 ID - Zaknun2013 ER - TY - JOUR AU - Pol, J. AU - Vöö, S. AU - Bucerius, J. AU - Mottaghy, F. M. PY - 2017 DA - 2017// TI - Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review JO - Eur J Nucl Med Mol Imaging VL - 44 UR - https://doi.org/10.1007/s00259-017-3675-7 DO - 10.1007/s00259-017-3675-7 ID - Pol2017 ER - TY - JOUR AU - Schlenkhoff, C. D. AU - Essler, M. AU - Ahmadzadehfar, H. PY - 2017 DA - 2017// TI - Possible treatment approach to an extravasation of 177Lu-PSMA-617 JO - Clin Nucl Med VL - 42 UR - https://doi.org/10.1097/RLU.0000000000001715 DO - 10.1097/RLU.0000000000001715 ID - Schlenkhoff2017 ER - TY - JOUR AU - Jüptner, M. AU - Zuhayra, M. AU - Assam, I. AU - Lützen, U. PY - 2018 DA - 2018// TI - Successful handling of an accidental extravasation of 177Lu-PSMA-617 in the treatment of advanced prostate cancer JO - Nuklearmedizin VL - 57 UR - https://doi.org/10.1055/s-0038-1641692 DO - 10.1055/s-0038-1641692 ID - Jüptner2018 ER - TY - JOUR AU - Arveschoug, A. K. AU - Bekker, A. C. AU - Iversen, P. AU - Bluhme, H. AU - Villadsen, G. E. AU - Staanum, P. F. PY - 2020 DA - 2020// TI - Extravasation of [177Lu]Lu-DOTATOC: case report and discussion JO - EJNMMI Res VL - 10 UR - https://doi.org/10.1186/s13550-020-00658-6 DO - 10.1186/s13550-020-00658-6 ID - Arveschoug2020 ER - TY - JOUR AU - Cheong, B. AU - Muthupillai, R. AU - Rubin, M. F. AU - Flamm, S. D. PY - 2007 DA - 2007// TI - Normal values for renal length and volume as measured by magnetic resonance imaging JO - Clin J Am Soc Nephrol VL - 2 UR - https://doi.org/10.2215/CJN.00930306 DO - 10.2215/CJN.00930306 ID - Cheong2007 ER - TY - JOUR AU - Sandström, M. AU - Garske, U. AU - Granberg, D. AU - Sundin, A. AU - Lundqvist, H. PY - 2010 DA - 2010// TI - Individualized dosimetry in patients undergoing therapy with 177 Lu-DOTA-D-Phe 1-Tyr 3-octreotate JO - Eur J Nucl Med Mol Imaging VL - 37 UR - https://doi.org/10.1007/s00259-009-1216-8 DO - 10.1007/s00259-009-1216-8 ID - Sandström2010 ER - TY - JOUR AU - Gear, J. I. AU - Cox, M. G. AU - Gustafsson, J. AU - Gleisner, K. S. AU - Murray, I. AU - Glatting, G. AU - Konijnenberg, M. AU - Flux, G. D. PY - 2018 DA - 2018// TI - EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations JO - Eur J Nucl Med Mol Imaging VL - 45 UR - https://doi.org/10.1007/s00259-018-4136-7 DO - 10.1007/s00259-018-4136-7 ID - Gear2018 ER - TY - JOUR AU - Barré, E. AU - Nguyen, M. L. AU - Bruel, D. AU - Fournel, C. AU - Hosten, B. AU - Lao, S. AU - Vercellino, L. AU - Rizzo-Padoin, N. PY - 2013 DA - 2013// TI - Extravasation des médicaments radiopharmaceutiques: mesures préventives et prise en charge recommandées par la SoFRa (Société française de radiopharmacie) JO - Ann Pharm Fr VL - 71 UR - https://doi.org/10.1016/j.pharma.2013.05.001 DO - 10.1016/j.pharma.2013.05.001 ID - Barré2013 ER - TY - JOUR AU - Bolch, W. E. AU - Eckerman, K. F. AU - Sgouros, G. AU - Thomas, S. R. PY - 2009 DA - 2009// TI - MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry—standardization of nomenclature JO - J Nucl Med VL - 50 UR - https://doi.org/10.2967/jnumed.108.056036 DO - 10.2967/jnumed.108.056036 ID - Bolch2009 ER - TY - JOUR AU - Rueden, C. T. AU - Schindelin, J. AU - Hiner, M. C. AU - DeZonia, B. E. AU - Walter, A. E. AU - Arena, E. T. AU - Eliceiri, K. W. PY - 2017 DA - 2017// TI - ImageJ2: ImageJ for the next generation of scientific image data JO - BMC Bioinformatics VL - 18 UR - https://doi.org/10.1186/s12859-017-1934-z DO - 10.1186/s12859-017-1934-z ID - Rueden2017 ER - TY - JOUR AU - Stabin, M. AU - Siegel, J. AU - Hunt, J. AU - Sparks, R. AU - Lipsztein, J. AU - Eckerman, K. PY - 2001 DA - 2001// TI - RADAR: the radiation dose assessment resource—an online source of dose information for nuclear medicine and occupational radiation safety JO - J Nucl Med VL - 42 ID - Stabin2001 ER - TY - JOUR AU - Shapiro, B. AU - Pillay, M. AU - Cox, P. PY - 1987 DA - 1987// TI - Dosimetric consequences of interstitial extravasation following iv administration of a radiopharmaceutical JO - Eur J Nucl Med VL - 12 UR - https://doi.org/10.1007/BF00620478 DO - 10.1007/BF00620478 ID - Shapiro1987 ER - TY - JOUR AU - Balter, S. AU - Hopewell, J. W. AU - Miller, D. L. AU - Wagner, L. K. AU - Zelefsky, M. J. PY - 2010 DA - 2010// TI - Fluoroscopically guided interventional procedures: a review of radiation effects on patients’ skin and hair JO - Radiology VL - 254 UR - https://doi.org/10.1148/radiol.2542082312 DO - 10.1148/radiol.2542082312 ID - Balter2010 ER - TY - JOUR AU - Bonta, D. V. AU - Halkar, R. K. AU - Alazraki, N. PY - 2011 DA - 2011// TI - Extravasation of a therapeutic dose of 131I-metaiodobenzylguanidine: prevention, dosimetry, and mitigation JO - J Nucl Med VL - 52 UR - https://doi.org/10.2967/jnumed.110.083725 DO - 10.2967/jnumed.110.083725 ID - Bonta2011 ER - TY - JOUR AU - Williams, G. AU - Palmer, M. R. AU - Parker, J. A. AU - Joyce, R. PY - 2006 DA - 2006// TI - Extravazation of therapeutic Yttrium-90-Ibritumomab tiuxetan (Zevalin®): a case report JO - Cancer Biother Radiopharm VL - 21 UR - https://doi.org/10.1089/cbr.2006.21.101 DO - 10.1089/cbr.2006.21.101 ID - Williams2006 ER - TY - STD TI - ICRP. The 2007 recommendations of the international commission on radiological protection. ICRP Publication 103. 2007;37(2-4). https://www.icrp.org/publication.asp?id=ICRP%20Publication%20103. UR - https://www.icrp.org/publication.asp?id=ICRP%20Publication%20103 ID - ref19 ER - TY - JOUR AU - Uribe, C. F. AU - Esquinas, P. L. AU - Gonzalez, M. AU - Zhao, W. AU - Tanguay, J. AU - Celler, A. PY - 2018 DA - 2018// TI - Deadtime effects in quantification of 177 Lu activity for radionuclide therapy JO - EJNMMI Phys VL - 5 UR - https://doi.org/10.1186/s40658-017-0202-7 DO - 10.1186/s40658-017-0202-7 ID - Uribe2018 ER -